These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease. Korzenik JR; Podolsky DK Clin Gastroenterol Hepatol; 2006 Feb; 4(2):157-9. PubMed ID: 16469674 [No Abstract] [Full Text] [Related]
28. [What do the guidelines say?]. Stiefelhagen P MMW Fortschr Med; 2016 Mar; 158(6):22. PubMed ID: 27084139 [No Abstract] [Full Text] [Related]
29. Arthritis. Steps for staying active. Mayo Clin Health Lett; 2005 Oct; Suppl():1-8. PubMed ID: 16320424 [No Abstract] [Full Text] [Related]
30. Rheumatoid arthritis drug update. Johns Hopkins Med Lett Health After 50; 2008 May; 20(3):4-5, 7. PubMed ID: 18652033 [No Abstract] [Full Text] [Related]
31. [Coxibes--bullying of a drug class?]. Müller P; Simon B MMW Fortschr Med; 2008 Jun; 150 Suppl 2():63-4. PubMed ID: 18712125 [No Abstract] [Full Text] [Related]
32. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do? Lazzaroni M; Battocchia A; Bianchi Porro G Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794 [TBL] [Abstract][Full Text] [Related]
33. Celecoxib safety revisited. Med Lett Drugs Ther; 2016 Dec; 58(1510):159. PubMed ID: 27960193 [No Abstract] [Full Text] [Related]
34. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Marzo-Ortega H; Green MJ; Keenan AM; Wakefield RJ; Proudman S; Emery P Arthritis Rheum; 2007 Feb; 57(1):154-60. PubMed ID: 17266089 [TBL] [Abstract][Full Text] [Related]
35. Understanding the COX-2/NSAID dilemma. Roth SH Drugs; 2005; 65(14):1915-7. PubMed ID: 16162017 [No Abstract] [Full Text] [Related]
36. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor. Mukherjee D Thromb Haemost; 2006 Oct; 96(4):407-12. PubMed ID: 17003915 [TBL] [Abstract][Full Text] [Related]
37. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain]. Nurmohamed MT Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165 [No Abstract] [Full Text] [Related]
38. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Scheiman JM Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260 [TBL] [Abstract][Full Text] [Related]
39. Clin-IQ Project 2005. Salinas ; Yonahara M; Eppler J J Okla State Med Assoc; 2008 Feb; 101(2):34. PubMed ID: 18361031 [No Abstract] [Full Text] [Related]
40. Drug safety in Crohn's disease therapy. Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P Digestion; 2007; 76(2):161-8. PubMed ID: 18239408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]